It has been pointed out that UGP2, a key enzyme in glycogen biosynthesis (Looft et al., 2000; Mohammad et al., 2012), has been demonstrated to be related to the occurrence and development of a variety of cancers (Tan et al., 2014; Wang et al., 2018; Zeng et al., 2019), including hepatocellular carcinoma (HCC) (Zhou et al., 2012). This evidence concerns the gene UGP2 and hepatocellular carcinoma.